UNSPSC 85694501: Revision of nonautologous tissue substitute in left finger phalanx, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left finger phalanx, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PWVXKZ

UNSPSC 85694501 Revision of nonautologous tissue substitute in left finger phalanx, external approach is a Commodity code, yet the recent state and local opportunities posted under it reflect no medical device procurement aligned with orthopedic implant or tissue-substitute work. Instead, the code shows six recent solicitations spanning occupational medical surveillance, disability medical record review and evaluation coordination, surgical benefit carve-out administration, specialty pharmacy benefit management, temporary health professional staffing pools, and inpatient emergency care for detained youth — none of which involve tissue substitutes or finger phalanx repair. The mismatch suggests systematic miscoding of health services and benefits administration work into this narrow surgical-procedure code, or that the posting system has assigned unrelated medical and administrative services to an implant-specific commodity identifier. No state and local governments have solicited actual finger phalanx tissue-substitute products or revision procedures under this code in the recent activity block.

The six opportunities posted show issuing bodies across county health systems (Santa Clara, Collier County), city retirement pension offices (Phoenix), state transportation departments (Washington State Department of Transportation), county juvenile probation departments (Harris County), and city human resources and benefits offices (Long Beach), with response deadlines clustered between late August and early October 2026. Geographic spread includes Arizona, California, Florida, Texas, and Washington. Given the complete absence of scope alignment between the code's nominal definition and the work actually being bought, this code presents no actionable procurement signal for firms pursuing orthopedic implant, surgical device, or tissue-substitute contracts at the state and local level.